TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 DKK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
2,185,033
|
1,455,071
|
996,136 |
| Earnings before taxes |
734,058
|
357,124
|
198,119 |
| Total assets |
3,140,663
|
2,347,541
|
1,182,430 |
| Current assets |
2,112,445
|
1,611,089
|
624,925 |
| Current liabilities |
1,882,633
|
1,332,860
|
708,893 |
| Equity capital |
633,585
|
339,677
|
215,139 |
| - share capital |
42,853
|
42,853
|
42,853 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
20.2%
|
14.5%
|
18.2% |
| Turnover per employee |
6,243
|
4,157
|
2,846 |
| Profit as a percentage of turnover |
33.6%
|
24.5%
|
19.9% |
| Return on assets (ROA) | |||
| Current ratio |
112.2%
|
120.9%
|
88.2% |
| Return on equity (ROE) |
115.9%
|
105.1%
|
92.1% |
| Change turnover |
729,962
|
458,935
|
303,523 |
| Change turnover % |
50%
|
46%
|
44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.